UMMS Affiliation

Program in Gene Function and Expression

Date

7-13-2010

Document Type

Article

Medical Subject Headings

Africa; Cell Differentiation; Histone Deacetylase 1; Histone Deacetylase 2; *Histone Deacetylase Inhibitors; Humans; Infant; Protein Isoforms; RNA Interference

Disciplines

Genetics and Genomics | Hemic and Lymphatic Diseases

Abstract

The worldwide burden of sickle cell disease is enormous, with over 200,000 infants born with the disease each year in Africa alone. Induction of fetal hemoglobin is a validated strategy to improve symptoms and complications of this disease. The development of targeted therapies has been limited by the absence of discrete druggable targets. We developed a unique bead-based strategy for the identification of inducers of fetal hemoglobin transcripts in primary human erythroid cells. A small-molecule screen of bioactive compounds identified remarkable class-associated activity among histone deacetylase (HDAC) inhibitors. Using a chemical genetic strategy combining focused libraries of biased chemical probes and reverse genetics by RNA interference, we have identified HDAC1 and HDAC2 as molecular targets mediating fetal hemoglobin induction. Our findings suggest the potential of isoform-selective inhibitors of HDAC1 and HDAC2 for the treatment of sickle cell disease.

Comments

Citation: Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12617-22. Epub 2010 Jun 28. Link to article on publisher's site

Freely available online through the PNAS open access option.

Related Resources

Link to Article in PubMed

PubMed ID

20616024

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.